Results 121 to 130 of about 298,741 (199)

Human papillomavirus (HPV) vaccines [PDF]

, 2012
Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries.1 In South Africa, cervical cancer is the second most common ...
Hoosen, Anwar Ahmed, Visser, Adele
core  

Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Human papillomavirus (HPV) vaccination is a critical intervention for cervical cancer prevention in Africa; however, program uptake and scale‐up remain limited due to financing constraints. This scoping review mapped existing evidence on HPV vaccine financing in Africa, identifying prevailing funding mechanisms, cost ...
Kafayat Aminu, Jimoh Amzat, Rita Amarachi Nwebo, Precious Chika Nnannah, Chiamaka Norah Ezeagu, Aboyowa Arayuwa Edukugho, Olubukola Omobowale, Abba Shehu, Yovanthi Anurangi Jayasinghe, Ganiyat Amzat, Kehinde Kazeem Kanmodi   +10 more
wiley   +1 more source

Preliminary Development and Assessment of a Multiplex Assay for Human Papillomavirus Antibody Detection Using Commercial L1 Proteins

Journal of Clinical Laboratory Analysis, Volume 40, Issue 19, October 2026.
This study developed and assessed a new multiplex assay for the simultaneous detection of antibodies against multiple Human Papillomavirus (HPV) types. Using recombinant L1 protein, the assay quantifies IgG and IgA responses in human plasma, enabling comprehensive immune profiling across multiple high‐risk cancer‐associated HPV genotypes. This approach
Arash Aslanabadi, Maryam Karimi, Laura Powell, Lisa Schumaker, Ashley Shutt, Mahsa Hojabri, Rahim Abbasi, Søren M. Bentzen, Kevin J. Cullen, Trevor A. Crowell, Rebecca G. Nowak, Mohammad M. Sajadi   +11 more
wiley   +1 more source

Vaccines for human papillomavirus infection: A critical analysis [PDF]

, 2009
This article takes a critical look at the pros and cons of human papillomavirus (HPV) vaccines. There is enough evidence to suggest that the prophylactic vaccines are efficacious in preventing various benign and malignant conditions (including cervical ...
Nath, Amiya Kumar, Thappa, Devinder Mohan   +1 more
core   +1 more source

Adjuvant HPV Vaccination and Survival in Oropharyngeal Squamous Cell Carcinoma: An Exploratory Analysis of a Real‐World Database

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
HPV vaccination after exposure may confer survival benefits in oropharyngeal cancer patients. Survival advantages appeared regardless of vaccination timing relative to diagnosis, though small sample sizes preclude definitive conclusions. ABSTRACT Objective Childhood HPV vaccination reduces oropharyngeal cancer (OPC) incidence, but evidence regarding ...
Mary Elizabeth Kim, Kevin Herrera, Albert Han, Kevin Hur, Niels Kokot, Mark S. Swanson   +5 more
wiley   +1 more source

The Impact of the HeLa Cell in the Field of Otolaryngology: Honoring Henrietta Lacks

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
This article provides a scoping review on how the HeLa cell has influenced the field of otolaryngology. Specifically, it discusses how rhinology, otology, laryngology, and head and neck cancer research was influenced by the HeLa cell. We also include a brief review of how HPV was identified in the HeLa cell and how this improved our understanding of ...
Taylor L. Jamil, Carissa M. Thomas, Scott Mann, Andrew P. Johnson, Cristina Cabrera‐Muffly   +4 more
wiley   +1 more source

Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region

Human Vaccines & Immunotherapeutics
There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong Kong, Indonesia, Japan, South Korea, Malaysia, the ...
Wanatpreeya Phongsamart, Pei-Jen Lou, Isaya Sukarom, Ying-Hui Wu, Omer Zaidi, Frieda Du, Alyssa Simon, Mark Bernauer   +7 more
doaj   +1 more source

Cervical Cancer Awareness and Attitude Towards Cervical Cancer Screening and Human Papillomavirus Vaccines Among Urban Women of Karachi, Pakistan. [PDF]

Cureus, 2023
Shahnaz S, Fricovsky E, Anwar R, Arain MI.   +3 more
europepmc   +1 more source

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis. [PDF]

Front Microbiol, 2022
Ren X, Hao Y, Wu B, Jia X, Niu M, Wang K, Li Z.   +6 more
europepmc   +1 more source